Genmab A/S (GNMSF) Return on Capital Employed (2025 - 2026)

Genmab A's (GNMSF) quarterly Return on Capital Employed came in at 16.8% in Q1 2026, down 58.08% on a QoQ basis from 40.07% in Q3 2025.

Genmab A/S (GNMSF) Return on Capital Employed (2025 - 2026) Analysis & Trends

Genmab A (GNMSF) has 2 years of Return on Capital Employed data on file, last reported at 16.8% in Q1 2026.

Quarterly Return on Capital Employed changed N/A year-over-year to 16.8% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.8% (changed N/A YoY) and the FY2025 annual result came in at 12.83%, changed N/A from the prior year.
Return on Capital Employed retreated to 16.8% in Q1 2026, from 40.07% in the prior quarter.
In the past five years, Return on Capital Employed ranged from a high of 40.07% in Q3 2025 to a low of 16.8% in Q1 2026.

Download Data